PM
FATE icon

Parametrica Management’s Fate Therapeutics FATE Stock Holding History

Parametrica Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.2K Hold
18,472
– – 0.03% 20
2025
Q4 		$18.2K Hold
18,472
– – 0.03% 22
2025
Q3 		$23.3K Hold
18,472
– – 0.04% 22
2025
Q2 		$20.7K Hold
18,472
– – 0.04% 26
2025
Q1 		$14.6K Hold
18,472
– – 0.02% 22
2024
Q4 		$30.5K Hold
18,472
– – 0.04% 64
2024
Q3 		$64.7K Hold
18,472
– – 0.08% 61
2024
Q2 		$60.6K Hold
18,472
– – 0.08% 21
2024
Q1 		$136K Hold
18,472
– – 0.2% 21
2023
Q4 		$69.1K Hold
18,472
– – 0.11% 27
2023
Q3 		$39.2K Hold
18,472
– – 0.07% 30
2023
Q2 		$87.9K Hold
18,472
– – 0.17% 27
2023
Q1 		$105K Sell
18,472
-13,782
-43% -$83.2K 0.19% 23
2022
Q4 		$325K Buy
32,254
+18,089
+128% +$340K 0.67% 28
2022
Q3 		$318K Sell
14,165
-724
-5% -$20.9K 0.65% 37
2022
Q2 		$371K Buy
14,889
+2,794
+23% +$77.1K 0.4% 65
2022
Q1 		$469K Sell
12,095
-4,971
-29% -$192K 0.35% 59
2021
Q4 		$999K Sell
17,066
-2,844
-14% -$161K 0.99% 31
2021
Q3 		$1.18M Buy
+19,910
New +$1.56M 0.88% 31
2021
Q1 		– Sell
-2,752
Closed -$250K – 190
2020
Q4 		$250K Buy
+2,752
New +$171K 0.15% 124

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parametrica Management's FATE Position: Q1 2026 in Review

Parametrica Management held its Fate Therapeutics (FATE) position steady in Q1 2026 at 18,472 shares worth $22.2K. The position accounts for 0.03% of the portfolio, ranked #20.

Parametrica Management first reported a position in FATE in Q4 2020 and has held it in 20 quarters since. The position peaked at $1.18M in Q3 2021. 157 funds tracked by Wall St. Rank hold FATE as of Q1 2026.

  • Parametrica Management held 18,472 shares of Fate Therapeutics worth $22.2K as of Q1 2026.
  • Parametrica Management left its Fate Therapeutics share count unchanged in Q1 2026.
  • Fate Therapeutics made up 0.03% of Parametrica Management's portfolio in Q1 2026, its #20 holding.
  • Parametrica Management first reported a position in Fate Therapeutics in Q4 2020 and has held it in 20 quarters since.
  • Parametrica Management's Fate Therapeutics position peaked at $1.18M in Q3 2021.
  • 157 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2026.

Based on Parametrica Management's 13F filing for Q1 2026, filed 11 May 2026.